Capital market regulator Sebi on Monday allowed Fresenius Kabi Oncology to delist its shares from the Indian stock market and asked the healthcare firm to complete the delisting process within three months -- bringing to an end a long-standing dispute.
first published: Jul 22, 2013 11:00 pm
A collection of the most-viewed Moneycontrol videos.
Point-to-Point vs Rolling Returns for Mutual Funds: Full Breakdown
From Hesitant Heir to Undisputed Leader: Sanjiv Bajaj's Leadership Story
Nifty Fails To Defend 26,000 Amid Sluggish Start To Final Week Of 2025| Closing Bell Live
Nifty Aims To Defend 26,000 Amid Thin Volumes, Record-Low VIX| Opening Bell Live
